[1]中华人民共和国卫生部疾病预防控制局, 中华人民共和国卫生部医政司,中国疾病预防控制中心.中国结核病防治规划实施工作指南(2008年版).北京:中国协和医科大学出版社,2009: 1.[2]World Health Organization.Policy guidance on drug-susceptibility testing (DST) of second-line anti-tuberculosis drugs. Geneva:World Health Organization,2008.[3]Kim SJ, Espinal MA, Abe C,et al. Is second-line anti-tuberculosis drug susceptibility testing reliable? Int J Tuber Lung Dis, 2004,8(9):1157-1158.[4]Chan ED, Iseman MD. Multidrug-resistant and extensively drug-resistant tuberculosis: a review. Curr Opin Infect Dis,2008, 21(6):587-595.[5]Abed Y, Davin-Regli A, Bollet C, et al.Efficient discrimination of Mycobacterium tuberculosis strains by 16S-23S spacer region-based random amplified polymorphic DNA analysis.J Clin Microbiol,1995,33(5):1418-1420.[6]Roth A, Fischer M, Hamid ME, et al.Differentiation of phylogenetically related slowly growing mycobacteria based on 16S-23S rRNA gene internal transcribed spacer sequences.J Clin Microbiol,1998,36(1):139-147.[7]Sansila A, Hongmanee P, Chuchottaworn C, et al.Differentiation between Mycobacterium tuberculosis and Mycobacterium avium by amplification of the 16S-23S ribosomal DNA spacer. J Clin Microbiol,1998,36(9):2399-2403.[8]赵立平,于霞,姜广路, 等. 对BACTETTM MGIT960培养报告结果为阴性的培养管中颗粒性物质的研究. 中国防痨杂志,2013,35(1):28-32.[9]Pang Y, Zhou Y, Zhao B,et al. Spoligotyping and drug resis-tance analysis of Mycobacterium tuberculosis strains from national survey in China. PLoS One, 2012,7(3):e32976.[10]逄宇,夏辉,姜广路,等.中国结核分枝杆菌寡核苷酸基因分型及其耐药性分析.中华检验医学杂志,2011, 34(11):1023-1028.[11]Cowan LS, Diem L, Monson T,et al. Evaluation of a two-step approach for large-scale, prospective genotyping of Mycobacterium tuberculosis isolates in the united States. J Clin Microbiol, 2005,43(2):688-695.[12]Minime-Lingoupou F, Pierre-Audigier C, Kassa-Kélémbho E, et al. Rapid identification of multidrug-resistant tuberculosis isolates in treatment failure or relapse patients in Bangui, Central African Republic. Int J Tuberc Lung Dis, 2010,14(6):782-785.[13]中国防痨协会基础专业委员会.结核病诊断实验室检验规程. 北京:中国教育文化出版社, 2006: 49-51.[14]Zhao Y, Xu S, Wang L, et al. National survey of drug-resis-tant tuberculosis in China. N Engl J Med, 2012,366(23):2161-2170.[15]Giampaglia CM, Martins MC, Chimara E,et al.Differentiation of Mycobacterium tuberculosis from other mycobacteria with P-nitrobenzoic acid using MGIT960. Int J Tuberc Lung Dis, 2007,11(7):803-807.[16]Parsons LM, Somoskovi A, Gutierrez C, et al. Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities. Clin Microbiol Rev, 2011,24(2):314-350.[17]Shen G, Xue Z, Shen X,et al. The study recurrent tuberculosis and exogenous reinfection, Shanghai, China. Emerg Infect Dis, 2006,12(11):1776-1778.[18]Viveiros M, Portugal I, Bettencourt R, et al. Isoniazid-induced transient high-level resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother,2002,46(9):2804-2810. |